Skip to main content

Market Overview

Catabasis Pharmaceuticals

CAT-1004, Catabasis Pharmaceuticals, CATB, DMD, Duchenne Muscular Dystrophy, MoveDMD

Shares Of Catabasis Pharmaceuticals See-Saw Following Results Of Duchenne Muscular Dystrophy Study
Monday, January 25, 2016 - 2:15pm | 218

Shares of Catabasis Pharmaceuticals Inc (NASDAQ: CATB), a clinical-stage small-cap biopharmaceutical company, were highly volatile during Monday's trading session after the company

Read More...